Incyte Corp (INCY)

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader…

3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall

By Chris Markoch, InvestorPlace Contributor Sep 20, 2023

Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy.

7 Biotech Stocks That Could Cure Your Portfolio Woes

By Josh Enomoto, InvestorPlace Contributor Apr 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

By Muslim Farooque, InvestorPlace Contributor Mar 21, 2023

These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio

7 Biotech Stocks That Will Make You Rich in 10 Years

By Josh Enomoto, InvestorPlace Contributor Jan 18, 2023

Although the health innovation space presents risks, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years.

Why These 7 Healthcare Stocks Could Soar in 2023

By Muslim Farooque, InvestorPlace Contributor Jan 2, 2023

These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.

7 Undervalued Biotech Stocks to Buy Before They Boom

By Josh Enomoto, InvestorPlace Contributor Dec 29, 2022

While medical innovations offer tremendous appeal, investors can still get a discount in this sector via undervalued biotech stocks to buy.

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond

By Thomas Niel, InvestorPlace Contributor Dec 18, 2022

As their respective catalysts (namely new treatments/products) continue to play out, each one of these seven hottest healthcare stocks has a strong chance of making another significant move higher in 2023, and in the years ahead.

7 Cash-Rich Stocks to Buy for Peace of Mind

By Will Ashworth, InvestorPlace Contributor Nov 4, 2022

It pays to hold cash-rich stocks that can weather any storm because of their financial strength. These seven stocks are such companies.

3 Nasdaq Stocks to Buy Now for Growth

By Tezcan Gecgil, InvestorPlace Contributor May 1, 2022

These are the best Nasdaq stocks to invest in now. INCY, ROKU and FTXL can make great investments in the rest of the year.

7 Insider Stocks to Buy as Execs Snap Them Up

By Josh Enomoto, InvestorPlace Contributor Feb 18, 2022

With equity prices soaring to record levels, many execs have cashed out. Here are the insider stocks where execs are cashing in.

7 CEOs That Ought to Follow Jack Dorsey Out the Door

By Will Ashworth, InvestorPlace Contributor Dec 10, 2021

Jack Dorsey stepped down as Twitter CEO on Nov. 29. Running two companies, his move was predictable. Here are seven CEOs who also should go.

7 Beaten Down Stocks With Significant Insider Buying

By Mark Putrino, CMT Mar 1, 2021

If the insiders are buying, other investors should at least pay attention. These seven stocks are ones to keep an eye on here.

7 Beautiful Biotech Stocks to Buy Here

By Louis Navellier and the InvestorPlace Research Staff Apr 24, 2020

Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.

Stock Market Today: Is the Rally Ruined?; Tesla’s New Record

By Bret Kenwell, InvestorPlace Contributor Jan 3, 2020

Stocks were hit for what feels like the first time in a long time. Here's what happened in the stock market today.

Incyte News: INCY Stock Tumbles 10% on Experimental Drug Study Failure

By William White, InvestorPlace Writer Jan 3, 2020

Incyte (INCY) news for Friday about a recent clinical trial failing to meet its endpoints has INCY stock taking a beating.

Don't overlook NASDAQ:INCY—a stock with solid growth prospects and a reasonable valuation.

From Chartmill Apr 26, 2024

In the world of growth stocks, NASDAQ:INCY shines as a value proposition.

When you look at NASDAQ:INCY, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.

From Chartmill Apr 17, 2024

Don't overlook INCYTE CORP (NASDAQ:INCY)—it's a hidden gem with strong fundamentals and an attractive price tag.

Incyte Corp (INCY)

INCY Stock Earnings: Incyte Misses EPS, Misses Revenue for Q1 2024

Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Incyte Corp (INCY)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

INCY Stock Predictions, Articles, and Incyte Corp News

Subscriber Sign in